Catalysts for Amzell Limited
12 tracked
Mar 27, 2026
approval
LICART (DICLOFENAC EPOLAMINE) — FDA approval
Amzell Limited
→
Jan 1, 2025
recall
MXBBB recall (Cls II)
Amzell Limited
→
Dec 11, 2024
recall
Boulla LLC recall (Cls I)
Amzell Limited
→
Dec 11, 2024
recall
Boulla LLC recall (Cls I)
Amzell Limited
→
Dec 11, 2024
recall
Boulla LLC recall (Cls I)
Amzell Limited
→
Dec 11, 2024
recall
Boulla LLC recall (Cls I)
Amzell Limited
→
Nov 21, 2024
approval
LICART (DICLOFENAC EPOLAMINE) — FDA approval
Amzell Limited
→
May 23, 2024
approval
LICART (DICLOFENAC EPOLAMINE) — FDA approval
Amzell Limited
→
Apr 28, 2021
approval
LICART (DICLOFENAC EPOLAMINE) — FDA approval
Amzell Limited
→
May 14, 2020
approval
LICART (DICLOFENAC EPOLAMINE) — FDA approval
Amzell Limited
→
Jan 13, 2020
approval
LICART (DICLOFENAC EPOLAMINE) — FDA approval
Amzell Limited
→
Dec 19, 2018
approval
LICART (DICLOFENAC EPOLAMINE) — FDA approval
Amzell Limited
→